Fighting cancer with nanoparticles

Description

It is an undeniable milestone for science, academia and the pharmaceutical industry. If this treatment works, it could not only provide a cure for one of the world’s deadliest cancers, pancreatic cancer, but also open up a new therapeutic option for other types of deadly tumours that currently have no cure. This is how José Antonio López-Guerrero, head of the Molecular Biology Laboratory at the Valencian Institute of Oncology (IVO), describes the nanotechnology-based treatment he is working on as part of the European Ulises project. His innovative strategy consists mainly of delivering genetic material to the tumour cells to make them visible to the immune system, thus triggering a kind of “vaccine effect”. The key to this is the use of nanoparticles, similar to those used in the Covid-19 vaccine, synthesised by the Research Institute for Molecular Detection and Technological Development in Valencia. By targeting only tumour cells, this new treatment would also avoid most of the side effects of current therapies such as chemotherapy and radiotherapy.

Downloads

By downloading any of the following media, you agree to the Consent to Rights of Use.

Video Fighting cancer with nanoparticles

  • 1920x1080
  • 448.39 MB
  • 25fps, h264, mp4
Video Script

BRoll footage Fighting cancer with nanoparticles

  • 12:05
  • 1920x1080
  • 700.81 MB
  • 25fps, h264, mp4
Footage Shot List

Full interview Fighting caner with nanoparticles - Full Interviews of all Experts & Patients

  • 13:18
  • 1920x1080
  • 770.33 MB
  • 25fps, h264, mp4
Full Interviews Transcript

Photos Fighting caner with nanoparticles - Photos

  • 2.21 MB
  • 6
Photos

Press release Fighting caner with nanoparticles

  • 1920x1080
  • 1.73 MB
  • mp4, 25fps, h264
Press Release

Related stories

Welcome back

Create an account

Register

I already have an account

Consent to rights of use subject to conditions

We grant the following rights of use on the condition that:

The content is used for editorial purposes and not for commercial advertising or any other commercial use.

The following is agreed upon:

  1. we grant journalists, associations, scientists, organisations and other interested parties the non-exclusive right to use the photos, texts and videos (hereinafter referred to as “content”) provided by us and made available here for download for editorial purposes.
  2. The use of the content is permitted in all media, including print publications, online platforms, and social media.
  3. you may edit the content, provided that the edits do not distort the content or take the content out of its context.
  4. Attribution is not required.
  5. Use of the content for purely commercial purposes, such as advertising or promotion, is not permitted without our expressed written consent.
  6. These rights of use commence at the time the content is downloaded and are perpetual.
  7. You may not transfer these rights of use to any third party unless such third party agrees to be bound by the same terms, conditions and restrictions as those set out herein.
  8. These rights of use apply only to the content provided by us and do not extend to any other content or works.

By downloading the content, the user agrees to be bound by the foregoing terms and conditions.

Science Stories offers compelling stories, free video footage, interviews and other content related to European research projects under the Consents to rights of use.

Popular topics:

Follow us

Subscribe to our newsletter